399 related articles for article (PubMed ID: 23835910)
1. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.
Rodilla E; Pascual JM; Costa JA; Martin J; Gonzalez C; Redon J
J Hypertens; 2013 Aug; 31(8):1683-91. PubMed ID: 23835910
[TBL] [Abstract][Full Text] [Related]
2. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
5. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
Pierdomenico SD; Lapenna D; Cuccurullo F
Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
[TBL] [Abstract][Full Text] [Related]
6. Nondipping pattern on 24-h ambulatory blood pressure monitoring is associated with left ventricular hypertrophy in chronic kidney disease.
Jaques DA; Müller H; Martinez C; De Seigneux S; Martin PY; Ponte B; Saudan P
Blood Press Monit; 2018 Oct; 23(5):244-252. PubMed ID: 29958233
[TBL] [Abstract][Full Text] [Related]
7. Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.
Pouleur AC; Uno H; Prescott MF; Desai A; Appelbaum E; Lukashevich V; Smith BA; Dahlöf B; Solomon SD;
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):483-90. PubMed ID: 21746765
[TBL] [Abstract][Full Text] [Related]
8. Microalbuminuria, left ventricular mass and ambulatory blood pressure in essential hypertension.
Redon J; Baldo E; Lurbe E; Bertolin V; Lozano JV; Miralles A; Pascual JM
Kidney Int Suppl; 1996 Jun; 55():S81-4. PubMed ID: 8743518
[TBL] [Abstract][Full Text] [Related]
9. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
[TBL] [Abstract][Full Text] [Related]
10. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
[TBL] [Abstract][Full Text] [Related]
11. Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA/KORA Augsburg Echocardiographic Substudy.
Lieb W; Mayer B; Stritzke J; Doering A; Hense HW; Loewel H; Erdmann J; Schunkert H
Nephrol Dial Transplant; 2006 Oct; 21(10):2780-7. PubMed ID: 16880179
[TBL] [Abstract][Full Text] [Related]
12. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
13. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension.
Assadi F
Pediatr Cardiol; 2007; 28(1):27-33. PubMed ID: 17308944
[TBL] [Abstract][Full Text] [Related]
14. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).
Lønnebakken MT; Izzo R; Mancusi C; Gerdts E; Losi MA; Canciello G; Giugliano G; De Luca N; Trimarco B; de Simone G
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275070
[TBL] [Abstract][Full Text] [Related]
15. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients.
Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
J Hum Hypertens; 2005 Jun; 19(6):471-7. PubMed ID: 15744331
[TBL] [Abstract][Full Text] [Related]
16. Systematic review on urine albumin testing for early detection of diabetic complications.
Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
[TBL] [Abstract][Full Text] [Related]
17. Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects.
Verdecchia P; Angeli F; Gattobigio R; Sardone M; Pede S; Reboldi GP
Am J Hypertens; 2006 May; 19(5):493-9. PubMed ID: 16647622
[TBL] [Abstract][Full Text] [Related]
18. Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system.
du Cailar G; Fesler P; Ribstein J; Mimran A
Hypertension; 2010 Nov; 56(5):865-70. PubMed ID: 20921428
[TBL] [Abstract][Full Text] [Related]
19. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
[TBL] [Abstract][Full Text] [Related]
20. The importance of left ventricular hypertrophy in human hypertension.
Kahan T
J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
